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The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. We provide some figures and 
tables with several indexes and indicators as well as an Analysis section that discusses a specific topic related 
with the pandemic. 
As for the predictions, we employ an empirical model, verified with the evolution of the number of confirmed 
cases in previous countries where the epidemic is close to conclude, including all provinces of China. The 
model does not pretend to interpret the causes of the evolution of the cases but to permit the evaluation of 
the quality of control measures made in each state and a short-term prediction of trends. Note, however, 
that the effects of the measures’ control that start on a given day are not observed until approximately 7-14 
days later. 
We show an individual report with 8 graphs and a summary table with the main indicators for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. 
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Situation and highlights 
Global situation 
Denmark, Finland, Sweden and Norway 
share a region of Europe and some 
cultural features. They faced the first 
wave with different strategies. Sweden, 
with a soft control policy, achieved 
higher incidences, as seen in the figure. 
In early September, the incidence of 
Sweden was surpassed by Denmark. 
We are especially interested on 
assessing the epidemiological behavior 
of these countries in recent months.  We 
want to assess whether we can also 
speak of a "second wave" in these 
countries. We look at the period from 
1/08/2020 to 7/10/2020 (see figures 
below). 
Unfortunately, there is significant growth 
in all of them. Their mean ρ7 of this period 
(Denmark 1.22, Finland 1.27, Sweden 
1.08, Norway 1.19) is comparable to that 
of other countries such as Spain or UK, 
although Sweden stands out positively 
with a lower growth rate.  
However, the current incidences are still 
not too worrying. The highest one is 
found in Denmark, with an incidence 
above 100, but it has been declining for 
about two weeks. The current situation in Finland and Norway can be understood because, despite suffering 
considerable growth, the incident cases of 1/8/2020 was very low (Finland 2.4 per 105, Norway 3.6). Denmark 
had a higher value (10.6) and Sweden even higher (28.0).  
We can conclude that this set of countries is also suffering a second growth, but they are very far from the 




• Czech Republic reports the highest 14-day cumulative incidence (396 per 105), with an empiric 
reproduction number of 1.5. These values situate the country as the one at highest risk, with an EPG 
close to 600. The Netherlands is also in a worrying situation (A14 of 307, ρ7 of 1.3, EPG of 409). 
• The list of countries with an EPG>100 increases from 17 to 20, adding Poland, Croatia and 
Switzerland. 
• United Kingdom data seem not reliable. Its indexes must be considered with caution until dataseries 
are validated.  
• Denmark remains with a ρ7 clearly below 1 (0.8), together with Estonia. 
 
Situation and trends per country 
Maps of current situation in EU countries. Colour scale is indicated in each legend. 
• Cumulative incidence: total number of reported cases per 100,000 inhabitants 
• A14: Cumulative incidence last 14 days per 100,000 inhabitants (active cases) 
• ρ7: Empiric reproduction number  
• EPG: Effective Potential Growth (𝐸𝐸𝐸𝐸𝐸𝐸 = 𝐴𝐴14 · 𝜌𝜌7) 
 



















(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2) EPG stands for Effective Growth Potential, which is the 
product of reported cumulative incidence of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). 





Situation of hospitalisations and ICUs in some EU countries. The analysis is done for those countries that 
report a historical series with current (active) number of patients in hospitals and ICUs1. We provide: 
• Current active hospitalisations and patients in ICU per 100,000 inhabitants. 
• Current absolute number of active hospitalisations and patients in ICU. 
• Rate of occupation of curative care hospital beds by Covid-19 patients (data from Eurostat 20182), 
only for hospitalisations. 
• Current rate of occupation with regards to the maximum Covid-19 occupation reached in this 
pandemic. 
• Weekly increase in Covid-19 patients in hospitals and ICUs. 
 






Situation and trends in some European regions3 
Table of current situation in Spain regions. Colour scale is indicated in each legend.  
 
Maps of current situation in Spanish regions. Colour scale is indicated in each legend. 











Table of current situation in Sweden regions. Colour scale is indicated in each legend.  
 
 









Table of current situation in Belgium regions. Colour scale is indicated in each legend.  
 
 




(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2) EPG stands for Effective Growth Potential, which is the 
product of reported cumulative incidence of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). 






Analysis: Handling uncertainty in epidemiological indicators.  
During this pandemic, we have focused our analyses on a basic set of indexes and indicators, in order to 
explain the epidemiological situation of European countries. This set has also been used to analyse the 
situation at a lower level: from regions to provinces and counties. The indexes that we used are based on the 
number of new cases reported by corresponding administrations. Nevertheless, the lower the level, the 
higher the inherent noise in data and, therefore, the higher the uncertainty associated to the indexes. 
Moreover, all relative values (e.g., 14-day cumulative incidence) may undergo huge variations when the 
referred population is low.   
In this assessment we want to evaluate the confidence intervals for the different epidemiological indicators 
that we use: empirical reproduction number (𝜌𝜌7), 14-day cumulative incidence (𝐴𝐴14) and effective potential 
growth (𝐸𝐸𝐸𝐸𝐸𝐸 = 𝜌𝜌7 · 𝐴𝐴14). The objective is to determine if there is any scale limitation on their use, as well as 
to interpret their dynamics with regards to relative population. We will use as case study a set of areas at 
different scales, starting from a Catalan city (Molins de Rei) and following with its immediate surroundings 
using different geographical levels (political and health areas). All of them are shown in Figure 1. In Table 1, 
size and population of each area are shown.  
Table 1. Areas used to compute the epidemiological indexes. Population and size for each area are shown. 
Area name Area type Population Size (km2) 
Molins de Rei City 25,868 16 
Baix Llobregat Centre i 
Fontsanta L’Hospitalet Nord 
Health Care Assistance Area (medium-sized 
health area) – HCAA  
432,011 140 
Baix Llobregat County (medium-sized political area) 818,883 490 
Metropolitana Sud 
Care Management Area (large health area) 
– CMA  
1,370,709 1,400 
Catalunya Autonomous Community – AC  7,653,845 32,000 
 
 
Figure 1. Location of different studied areas inside Spain. 
 
For each area, we have assessed the dynamics of daily new cases (7-day moving average) and the 
epidemiological indexes, using data using data from official sources. Figure 2 shows the evolution of all 









Figure 2. Epidemiological indicators in different areas. A-E Light blue bars: reported daily new cases; darker blue line: 7-day 
moving average of new cases. F-J Empirical reproduction number (𝜌𝜌7). K-O 14-day cumulative incidence (A14). P-T Effective 
potential growth (EPG). City: Molins de Rei; HCAA: Health Care Assistance Area (medium-sized health area); County: Baix 
Llobregat; CMA: Care Management Area (large-sized health area); AC: Catalunya. Data from official databases4. 






Assessment of the confidential intervals 
We can consider case detection to follow a binomial probability (other distributions can be considered 
obtaining similar results). Let us illustrate it with two examples: 
1) We detect 10 cases in a population of 10,000 inhabitants. Incidence probability distribution and its 
confidence intervals are shown in Figure 3A, 3B. 
2) We detect 1 case in a population of 10,000 inhabitants. Incidence probability distribution and its 




Figure 3. Possible incidences given a certain measurement. A Probability density function for a 
detection of 10 cases in 10,000 inhabitants. B Cumulative probability density function for a detection of 
10 cases in 10,000 inhabitants. C Probability density function for a detection of 1 case in 10,000 
inhabitants. D Cumulative probability density function for a detection of 1 case in 10,000 inhabitants. 
 
Using the binomial approximation, we can compute a 95% confidence interval for the measured number of 
new cases. Then, using propagation of errors theory, we can compute the confidence intervals of main 
indicators. 






Let us recall the definition of all indicators (Table 2). Using theory of propagation of errors,  











and assuming constant incidences we can obtain the uncertainties included in Table 2 (see appendix for 
detailed calculations).  
Table 2. Description and equation of assessed indicators and indexes, together with the evaluation of their uncertainty 
assuming constant incidence (see appendix). 
 Equation Uncertainty 
7-day moving average of new cases 𝑐𝑐 =






14-day cumulative incidence 𝐴𝐴14 =
𝑐𝑐0 + 𝑐𝑐1 + 𝑐𝑐2 + ⋯+ 𝑐𝑐13
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛




Empirical reproduction number 𝜌𝜌 =
𝑐𝑐0 + 𝑐𝑐1 + 𝑐𝑐2
𝑐𝑐5 + 𝑐𝑐6 + 𝑐𝑐7
 𝜎𝜎𝜌𝜌 ≈
√6
3 · √7 · 𝑛𝑛
𝜎𝜎𝑛𝑛 








Assuming Gaussian approximation (𝜎𝜎𝑛𝑛 ≈ 1.96 √𝑛𝑛), we can obtain a good analytical approximation for the 









































In figure 4, we plot epidemiological indicators with their confidence intervals. Note that confidence intervals 





Confidence intervals are reduced with the square root of the incidence and population. The bigger the 










Figure 4. Epidemiological indicators at different areas with 95% confidence intervals. A-E Light blue bars: reported daily new 
cases; darker blue line: 7-day moving average of new cases. F-J Empirical reproduction number (𝜌𝜌7). K-O 14-day cumulative 
incidence (A14). P-T Effective potential growth (EPG). City: Molins de Rei; HCAA: Health Care Assistance Area (medium-sized 






Assessment of the population threshold for an uncertainty below 10% 
Some calculations can be performed using the analytical approximations. Assuming a constant incidence of 
A14=100 cases per 100,000 inh., we compute which must be the population size in order to have a confidence 





� 10014 · 105 · 𝑝𝑝𝑝𝑝𝑝𝑝





� 10014 · 105 · 𝑝𝑝𝑝𝑝𝑝𝑝





� 10014 · 105 · 𝑝𝑝𝑝𝑝𝑝𝑝





� 10014 · 105 · 𝑝𝑝𝑝𝑝𝑝𝑝
= 0,10 → 𝑝𝑝𝑝𝑝𝑝𝑝 ≈ 560,000 
These results can also be computed numerically, as shown in Table 3 and in Figure 5. They are also assessed 
for an A14 of 200 cases per 100,000 inh.  
 
Table 3. Minimum population sizes need to have an uncertainty smaller than 10% in epidemiological 
indicators and indexes. Two different constant incidences are considered (𝐴𝐴14 = 100 and 𝐴𝐴14 = 200). 
Populations sizes are obtained numerically and with analytical approximations. 
 𝑨𝑨𝟏𝟏𝟏𝟏 = 𝟏𝟏𝟏𝟏𝟏𝟏 𝑨𝑨𝟏𝟏𝟏𝟏 = 𝟐𝟐𝟏𝟏𝟏𝟏 
numerically approximation numerically approximation 
7-day moving average 
in new cases (𝒄𝒄) 
820,000 770,000 410,000 380,000 
Empiric reproduction 
number (𝝆𝝆) 
560,000 510,000 280,000 260,000 
14-day cumulative 
incidence (𝑨𝑨𝟏𝟏𝟏𝟏) 
70,000 56,000 36,000 28,000 
Effective potential 
growth (𝑬𝑬𝑬𝑬𝑬𝑬) 






Figure 5. Relative errors of different epidemiological indicators. Blue line is plotted considering a 
constant A14=100, and red line is assessed considering a constant A14=100. A 7-day moving average (c). B 













• Confidence intervals are reduced with the square root of the incidence and population. 
Population size and incidence are inversely associated with confidence interval width. 
• Indicators are always important to detect a sudden increase in number of cases and the 
incidence trend in any area, independently of its size. 
• Population size must be considered to put values in context and interpret their meaning. When 
population is small, it is important to know that indicator strict value is just an approximation 






Confidence interval for the 7-day moving average of daily new cases: 
𝑐𝑐 =


























































· 7 · 𝜎𝜎𝑛𝑛2 → 𝜎𝜎𝑐𝑐 ≈
1
√7







Confidence interval for the 14-day cumulative incidence: 
𝐴𝐴14 =




















𝜎𝜎𝑛𝑛2 → 𝜎𝜎𝐴𝐴14 ≈
105
𝑝𝑝𝑝𝑝𝑝𝑝













Confidence interval for empirical propagation (𝜌𝜌7): 
𝜌𝜌 =
𝑐𝑐0 + 𝑐𝑐1 + 𝑐𝑐2









2 + 𝜎𝜎22� + �
𝜌𝜌





























Confidence intervals for Effective Potential Growth (EPG): 
𝐸𝐸𝐸𝐸𝐸𝐸 = 𝜌𝜌 · 𝐴𝐴14 
𝜎𝜎𝐸𝐸𝐸𝐸𝐸𝐸2 = 𝜌𝜌2 · 𝜎𝜎𝐴𝐴14













































Legend: Countries’ reports details 
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(2) Analysis and prediction of COVID-19 




































































(1) Data source 
Data are daily obtained from European Centre for Disease Prevention and Control (ECDC)5 and country official 
sources (when indicated). Daily data comprise, among others: total confirmed cases, total confirmed new 
cases, total deaths, total new deaths. It must be considered that the report is always providing data from 
previous day. In the document we use the date at which the datapoint is assumed to belong, i.e., report from 
15/03/2020 is giving data from 14/03/2020, the latter being used in the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for individual countries and for the UE+EFTA+UK as a 
whole: 
 Number of cumulative confirmed cases 
 Number of reported new cases 
 Number of cumulative deaths  
Then, two indicators are calculated and plotted, too: 
 Case fatality rate: number of cumulative deaths divided by the number of cumulative confirmed 
cases, and reported as a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑝𝑝 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑝𝑝 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t after applying a 7-day moving average 
to the new cases dataset, so that fluctuations (e.g., weekend effect) are smoothed.  
(3) Classification of countries according to their epidemic level: the scale Biocom-Cov 
Countries are assigned a degree in the discrete Biocom-Cov scale, which aims to facilitate a simple way of 
assessing the situation of the country. It is based on the level of daily new cases per 100,000 inhabitants as 
follows: 
Pandemic degree Daily new incident 

















(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model6 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic wave that is characterized by an 
initial exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied. Once in the tail, predictions work but the meaning of parameters is lost. 
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulative cases of the UE and of countries that accomplish two criteria: 4 
or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 200 cases. 
Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that accomplish 
the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s Curve 
Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of fitted 
parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K cannot 
be correctly evaluated. In fact, at this stage the most relevant parameter is a.  
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases (3-5 
days). The confidence interval of predictions is assessed with the Matlab function predint, with a 99% 
confidence level. These predictions are shown in the plots as red dots with corresponding error bar. For series 
longer than 9 timepoints, last 3 points are weighted in the fitting so that changes in tendencies are well 
captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors7 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
                                                          
6 Madden LV. Quantification of disease progression. Protection Ecology 1980; 2: 159-176. 
7 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 




due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
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